About HATIP

A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.

Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.

Other supporters include Positive Action GlaxoSmithKline (founding sponsor); Abbott Fund; Abbott Molecular; Cavidi; Elton John AIDS Foundation; Merck & Co., Inc.; Pfizer Ltd; F Hoffmann La Roche; Schering Plough; and Tibotec, a division of Janssen Cilag.

latest aidsmap news

• Rare abacavir liver side-effects reported
• Abacavir treatment doesn't cause changes in biomarkers linked to heart attack, suggests small study
• Traditional healers could play key role in ART rollout
• HIV testing for mothers and children must expand, UN report shows
• London hospital to test new HIV vaccine candidate
• Counselling sessions can reduce reported risky sex by HIV-positive gay men
• HIV diagnoses in European MSM have almost doubled since 2000, UK tops the list
• Older HIV-positive gay men as likely to have risky sex as younger gay men with HIV
• Mbeki's opposition to ARVs cost 330,000 lives, shows study
• Universal testing and treatment could reduce new HIV infections in southern Africa by 95% in 10 years